ATP6V1B1
V-type proton ATPase subunit B, kidney isoform
Also known as: ATP6B1, RTA1B, VATB, VATB1_HUMAN, Vma2, VPP3
Cross-references: UniProt · Ensembl · Human Protein Atlas · GeneCards · NCBI Gene
Protein identityUniProt · HPA
- UniProt accession
- P15313
- Gene
- ATP6V1B1
- Ensembl
- ENSG00000116039
- Chromosome
- 2
- Canonical length
- 513 aa
- Protein class
- Disease related genes, Human disease related genes, Metabolic proteins, Potential drug targets, Predicted intracellular proteins, Transporters
- Subcellular location
- Nucleoplasm,Nuclear membrane
OverviewNCBI Gene
This gene encodes a component of vacuolar ATPase (V-ATPase), a multisubunit enzyme that mediates acidification of eukaryotic intracellular organelles. V-ATPase dependent organelle acidification is necessary for such intracellular processes as protein sorting, zymogen activation, receptor-mediated endocytosis, and synaptic vesicle proton gradient generation. V-ATPase is composed of a cytosolic V1 domain and a transmembrane V0 domain. The V1 domain consists of three A and three B subunits, two G subunits plus the C, D, E, F, and H subunits. The V1 domain contains the ATP catalytic site. The V0 domain consists of five different subunits: a, c, c', c'', and d. Additional isoforms of many of the V1 and V0 subunit proteins are encoded by multiple genes or alternatively spliced transcript variants. This encoded protein is one of two V1 domain B subunit isoforms and is found in the kidney. Mutations in this gene cause distal renal tubular acidosis associated with sensorineural deafness. [provided by RefSeq, Jul 2008]
Canonical amino-acid sequenceUniProt
513 residues, UniProt reviewed canonical sequence.
>P15313|ATP6V1B1
1 MAMEIDSRPG GLPGSSCNLG AAREHMQAVT RNYITHPRVT YRTVCSVNGP LVVLDRVKFA
61 QYAEIVHFTL PDGTQRSGQV LEVAGTKAIV QVFEGTSGID ARKTTCEFTG DILRTPVSED
121 MLGRVFNGSG KPIDKGPVVM AEDFLDINGQ PINPHSRIYP EEMIQTGISP IDVMNSIARG
181 QKIPIFSAAG LPHNEIAAQI CRQAGLVKKS KAVLDYHDDN FAIVFAAMGV NMETARFFKS
241 DFEQNGTMGN VCLFLNLAND PTIERIITPR LALTTAEFLA YQCEKHVLVI LTDMSSYAEA
301 LREVSAAREE VPGRRGFPGY MYTDLATIYE RAGRVEGRGG SITQIPILTM PNDDITHPIP
361 DLTGFITEGQ IYVDRQLHNR QIYPPINVLP SLSRLMKSAI GEGMTRKDHG DVSNQLYACY
421 AIGKDVQAMK AVVGEEALTS EDLLYLEFLQ KFEKNFINQG PYENRSVFES LDLGWKLLRI
481 FPKEMLKRIP QAVIDEFYSR EGALQDLAPD TALLocalizationUniProt · AlphaFold · HPA
Whether an antibody against ATP6V1B1 can act on the native protein depends on physical access: surface and secreted proteins are reachable by circulating antibodies, intracellular proteins usually are not.
- Antibody reachability
- Cell surface
- Secreted
- No
- Transmembrane segments
- 0
- Mean surface accessibility (rSASA)
- 0.28
- Highest tissue expression
- 132 nTPM
Expression across tissuesHPA
Tissue
- salivary gland: 132 nTPM
- kidney: 129 nTPM
- skin: 31 nTPM
- cervix: 29 nTPM
- placenta: 17 nTPM
- fallopian tube: 12 nTPM
Single-cell type
- epididymal clear cells: 167 nCPM
- salivary duct cells: 88 nCPM
- conjunctival goblet cells: 65 nCPM
- salivary ionocytes: 45 nCPM
- cytotrophoblasts: 42 nCPM
- renal collecting duct intercalated cells: 28 nCPM
Immune cell
- MAIT T-cell: 0.1 nTPM
- non-classical monocyte: 0.1 nTPM
- basophil: 0 nTPM
- classical monocyte: 0 nTPM
- eosinophil: 0 nTPM
- gdT-cell: 0 nTPM
Brain region
- cerebral cortex: 2.9 nTPM
- cerebellum: 2.6 nTPM
- amygdala: 2.1 nTPM
- white matter: 1.8 nTPM
- basal ganglia: 1.3 nTPM
- hippocampal formation: 1.3 nTPM
DiseaseUniProt · ClinVar · IEDB · PubMed
Four sources answering four different questions about ATP6V1B1.
Disease | AllUniProt
Conditions ATP6V1B1 is implicated in, by any mechanism.
- Renal tubular acidosis, distal, 2, with progressive sensorineural hearing loss (DRTA2) MIM:267300
Disease | GeneticClinVar
127 pathogenic / likely-pathogenic of 874 ClinVar records.
Conditions with pathogenic or likely-pathogenic variants.
- Renal tubular acidosis with progressive nerve deafness
- Inborn genetic diseases
- Distal renal tubular acidosis
- Renal tubulopathies
- ATP6V1B1-related disorder
Genetic constraint and essentialitygnomAD · DepMap
Does the body need this protein intact? Low LOEUF or a strong DepMap dependency means loss or blockade of the protein is likely to be felt.
- gnomAD LOEUF (loss-of-function intolerance)
- 0.95
- gnomAD pLI
- 0
- gnomAD missense Z
- 0.23
- DepMap mean gene effect
- -0.04
- DepMap dependency class
- none
Cancer expressionTCGA
Across TCGA tumor cohorts, this protein is over-expressed in roughly 4% of surveyed tumor types (aggregate summary; per-cohort expression, alteration, and survival load in the interactive view).
OntologyGO
Biological processes
- adult behavior
- ATP metabolic process
- calcium ion homeostasis
- chloride ion homeostasis
- inner ear morphogenesis
- olfactory behavior
- ossification
- pH reduction
- potassium ion homeostasis
- prostaglandin metabolic process
- proton transmembrane transport
- regulation of gene expression
- regulation of macroautophagy
- regulation of pH
- renal sodium excretion
- renal sodium ion transport
- renal tubular secretion
- renal water homeostasis
- sensory perception of sound
- synaptic vesicle lumen acidification
- vacuolar acidification
- vacuolar proton-transporting V-type ATPase complex assembly
Molecular functions
- ATP binding
- protein-containing complex binding
- proton transmembrane transporter activity
- proton-transporting ATPase activity, rotational mechanism
Cellular components
Protein domainsUniProt · Pfam · InterPro
- ATPase, F1/V1/A1 complex, alpha/beta subunit, nucleotide-binding domain
- ATPase, F1/V1/A1 complex, alpha/beta subunit, N-terminal domain
- ATPase, V1 complex, subunit B
- ATPase, alpha/beta subunit, nucleotide-binding domain, active site
- V-type ATP synthase regulatory subunit B/beta
- P-loop containing nucleoside triphosphate hydrolase
- ATP synthase A/B type, C-terminal domain
- ATP synthase alpha/beta family, nucleotide-binding domain
- ATP synthase alpha/beta family, beta-barrel domain
- C-terminal domain of V and A type ATP synthase
KeywordsUniProt
InteractionsUniProt · HPA
Protein binding partners of ATP6V1B1 in the human serome: UniProt-annotated complex subunits plus reported interactors. Each links to its own Seroatlas record.
Antibody and autoantibody relevanceSeroatlas analysis
Seroatlas reads ATP6V1B1 as an antibody target. Whether an autoantibody or antibody against ATP6V1B1 could matter depends on whether native ATP6V1B1 is physically reachable, whether the body needs it intact, and whether it acts in a disease-relevant tissue.
ATP6V1B1 is annotated at the cell surface, where native ATP6V1B1 is exposed to circulating antibodies and is a prime autoantibody target that could block, deplete, or overstimulate it.
Annotation status
The present source text does not explicitly label ATP6V1B1 as an autoantigen. Seroatlas presents hypothesis context only and does not manufacture a known-serology claim.
Loading the interactive Seroatlas protein explorer...